Review of the Post-COVID-19 Syndrome Associated with Acute Telogen Effluvium

July 2023 in “ Zenodo (CERN European Organization for Nuclear Research) ”

Grecia Chávez-Chavira

post-COVID-19 syndrome acute telogen effluvium hair loss diffuse non-scarring hair loss systemic febrile illness severe stress TE

Preprint — not peer reviewed. This was posted to a preprint server or data repository. It has not been through a journal's review process, and its findings may change or not hold up.

Studysummary In this review, researchers reported that post-COVID-19 syndrome may lead to significant sequelae like hair loss, potentially due to acute telogen effluvium, affecting around 20% of patients and impacting their quality of life, though specific studies on this relationship are lacking.

Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer

View this study on pmc.ncbi.nlm.nih.gov →

Discuss this study in the Community →

Research cited in this study

18 / 18 results

research Intermittent Chronic Telogen Effluvium With an Unusual Dermoscopic Finding Following COVID-19

2 citations , August 2022 in “Clinical Case Reports”

This case report describes a 17-year-old girl with telogen effluvium and severe hair loss following a suspected COVID-19 infection and a history of similar episodes since childhood.

research Covid Induced Telogen Effluvium: An Insight

4 citations , June 2022 in “Indian Dermatology Online Journal”

This review discusses post-COVID hair loss, attributing it to potential pathogenic factors like cytokines and viral effects, and suggests that full recovery without specific treatment is expected.

research COVID-19 Induced Telogen Effluvium

22 citations , October 2021 in “Dermatologic Therapy”

This study found that approximately one-quarter of post-COVID-19 patients experienced telogen effluvium, with a higher incidence among women, hospitalized patients, and those with hypertension or respiratory symptoms.

research COVID-19 Infection Is a Major Cause of Acute Telogen Effluvium

25 citations , August 2021 in “Irish Journal of Medical Science (1971 -)”

This study found that COVID-19 infection is a frequent cause of acute telogen effluvium, leading to excessive hair loss within 2–3 months after infection.

Trichodynia and Telogen Effluvium in COVID-19 Patients: Results of an International Expert Opinion Survey on Diagnosis and Management

research Trichodynia and Telogen Effluvium in COVID-19 Patients: Results of an International Expert Opinion Survey on Diagnosis and Management

39 citations , August 2021 in “JAAD International”

This study found that telogen effluvium and trichodynia are common in patients after COVID-19, and their severity may be influenced by the severity of the COVID-19 infection.

research Time of Onset and Duration of Post-COVID-19 Acute Telogen Effluvium

32 citations , July 2021 in “Journal of The American Academy of Dermatology”

This study found that acute telogen effluvium after COVID-19 typically began about 1.5 months post-infection and resolved sooner than typical cases, with most resolving in under two months.

research Pathobiology Questions Raised by Telogen Effluvium and Trichodynia in COVID-19 Patients

18 citations , April 2021 in “Experimental Dermatology”

This study in Italy observed telogen effluvium and trichodynia as common hair-related complications following COVID-19 infection, raising questions about underlying hair follicle biology and potential receptor involvement.

research Telogen Effluvium Associated with COVID-19 Infection

44 citations , January 2021 in “Dermatologic Therapy”

This study suggests that COVID-19 infection may trigger telogen effluvium, a condition of hair shedding, though medication side effects and pandemic-related stress cannot be excluded as contributing factors.

research A Surge in the Incidence of Telogen Effluvium in Minority Predominant Communities Heavily Impacted by COVID-19

14 citations , December 2020 in “Journal of The American Academy of Dermatology”

This study observed a significant increase in telogen effluvium cases among people of color during the COVID-19 pandemic in NYC, notably affecting Hispanic/Latinx individuals.

research Telogen Effluvium: A Sequela of COVID-19

58 citations , November 2020 in “International Journal of Dermatology”

COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.

research SARS-CoV-2-Induced Telogen Effluvium: A Multicentric Study

51 citations , November 2020 in “Journal of the European Academy of Dermatology and Venereology”

This article discusses SARS-CoV-2-induced telogen effluvium in a multicentric study and reports no new clinical results.

research Telogen Effluvium Related to Post Severe SARS-CoV-2 Infection: Clinical Aspects and Our Management Experience

35 citations , November 2020 in “Dermatologic Therapy”

This case series reports telogen effluvium in three patients following severe Sars-Cov-2 infection and suggests a potential association that merits further investigation.

research Prolonged and Late-Onset Symptoms of Coronavirus Disease 2019

88 citations , October 2020 in “Open Forum Infectious Diseases”

This study discusses hair loss as a potential late-onset symptom of COVID-19 recovery, with androgenic alopecia and telogen effluvium suggested as possible causes, but provides no new clinical results.

research A Review of the Dermatological Manifestations of Coronavirus Disease 2019 (COVID-19)

26 citations , August 2020 in “Dermatology Research and Practice”

This review discusses the various skin manifestations and problems related to COVID-19 and associated treatments, but it reports no new clinical findings.

research Relative Changes in the Pattern of Diseases Presenting in Dermatology Outpatient Clinic in the Era of the COVID-19 Pandemic

43 citations , July 2020 in “Dermatologic Therapy”

This study observed a significant increase in certain dermatologic conditions a month and two months after the onset of the COVID-19 pandemic in Turkey, which may suggest a link with asymptomatic COVID-19 infection.

Management of Telogen Effluvium During the COVID-19 Emergency: Psychological Implications